Ayden Charlene Cooper

405 citations
23 papers · 246 indexed · h-index 12

Ayden Charlene Cooper

23 papers receiving 242 citations

Peers

Ayden Charlene Cooper
Comparison fields: 5 of 83
  • Reproductive Medicine 28
  • Obstetrics and Gynecology 21
  • Internal Medicine 10
  • Nephrology 17
  • Hematology 24
Replace Jaskamal Padda with:
Jaskamal Padda United States
Khizer Khalid United States
Rizk Elbaz Egypt
Nazlı Gönç Türkiye
Colin Carr United Kingdom
Kuralay Atageldiyeva Kazakhstan
Eduarda Pizarro Spain
Paola Boni Italy
Özlem Turhan İyidir Türkiye
Guanping Dong China
Ayden Charlene Cooper relative to Jaskamal Padda United States Jaskamal Padda's profile →
Citations per field
00.5×1.5×
Jaskamal Padda · 1×
Citations per year

Countries citing papers authored by Ayden Charlene Cooper

Since Specialization
Citations

This map shows the geographic impact of Ayden Charlene Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayden Charlene Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayden Charlene Cooper more than expected).

Fields of papers citing papers by Ayden Charlene Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayden Charlene Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayden Charlene Cooper. The network helps show where Ayden Charlene Cooper may publish in the future.

Co-authorship network

The 12 scholars most cited alongside Ayden Charlene Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ayden Charlene Cooper Line = papers co-authored together Ayden Charlene Cooper links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20231
2 20239
3 20221
4 202120
5 202115
6 202111
7 202112
8 202117
9 20212
10 202112
11 202112
12 202118
13 202114
14 202118
15 20218
16 202113
17 202113
18 202115
19 20216
20 19954

About Ayden Charlene Cooper

Ayden Charlene Cooper is a scholar working on Genetics, Reproductive Medicine and Nephrology, having authored 23 papers that have together received 246 indexed citations. Recurring topics across this work include Pregnancy and preeclampsia studies (2 papers), Virus-based gene therapy research (2 papers), Case Reports on Hematomas (2 papers), Ovarian function and disorders (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Hemoglobinopathies and Related Disorders (2 papers), Gout, Hyperuricemia, Uric Acid (2 papers) and Pain Management and Opioid Use (1 paper). The work is most often cited by research in Reproductive Medicine (28 citations), Obstetrics and Gynecology (21 citations) and Internal Medicine (10 citations). Ayden Charlene Cooper has collaborated with scholars based in United States, Curacao and Pakistan. Frequent co-authors include Gutteridge Jean-Charles, Khizer Khalid, Jaskamal Padda, Anwar Khedr, Nitya Batra, Roshini Pradeep, Dina A. Ismail, Jayant Kumar Yadav, Muhammad Abdullah and M. Khalid. Their work appears in journals such as Animal Science and Cureus.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026